This study provides compelling evidence that SLC7A11 may serve as a potential therapeutic target for trastuzumab-resistant HER2-positive breast cancer. While the findings are well-supported by robust ...

Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic properties. It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT ...

In our study published in the Journal of the American Chemical Society, our team from The University of Hong Kong and ...

Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment.

The points-system-based weight loss program filed for bankruptcy on May 6, with its premarket value plummeting 52% by Wednesday morning. A growing debt burden forced the company to scale back ...

The pill, poised to revolutionize the weight loss world, may be up for FDA approval in late 2025. A daily pill to rival Ozempic is one step closer to hitting the market. Pharmaceutical giant Eli ...

Ozempic, initially for type 2 diabetes, has gained popularity for rapid weight loss, leading to a newly reported side effect dubbed "Ozempic feet." This condition results from the sudden loss of ...

This Is Us' star Chrissy Metz debuted her 100 lb. weight loss in May 2025 Jeffrey Mayer/WireImage ; Leah Puttkammer/FilmMagic Chrissy Metz is opening up about her health journey. Metz — who rose ...

A team of researchers based in Japan has revealed the molecular mechanisms underpinning the process for small EVs (sEVs), which they said could have implications for developing better cancer ...

NEW YORK, May 10 (Reuters) - Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the fate of WeightWatchers, which declared ...